中國光大控股(0165.HK)直線拉昇漲超2% 部分高管已認購可購買公司股份的基金
格隆匯11月1日丨中國光大控股(0165.HK)直線拉昇漲2.06%,報11.88港元,暫成交2555萬港元,最新總市值200億港元。公司昨日公告稱,某些高級管理成員已認購BIAM Everbright Fund SP的參與性並可贖回股份。基金在二級市場已投資,並可能繼續投資最高達5000萬港元購買公司的股份。公告稱,公司高級管理成員通過基金自願購買股份使其利益與公司股東利益更加趨於一致,彰顯了對公司發展方向和長期投資價值的認可和信心,以及對公司業務所處行業中長期發展前景的樂觀態度。中金最新研報將光大控股目標價升至15港元,維持跑贏行業評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.